Symptonic

Pioneering the future of healthcare through voice analysis

Symptonic is a research initiative at Aalto University, supported by Business Finland's Research to Business funding, dedicated to developing advanced technology for reliable detection of various disorders through speech signal analysis.This non-invasive, cost-effective, and scalable approach aims to transform global healthcare by enabling early detection and monitoring of diseases.

• Help shape Symptonic. Take our 5-min survey

Initial focus

Our initial focus is on dysphonia, a voice disorder affecting speech production, often linked to neurological and respiratory conditions.By analyzing subtle changes in speech, our AI-driven platform provides clinicians with objective, real-time insights, enhancing the diagnosis and management of voice disorders.

Long-term vision: Comprehensive speech-based diagnostics

Building upon our dysphonia monitoring capabilities, we aim to expand our platform to offer a fully automated, personalized clinical pathway for various conditions, including:• Neurological disorders: Such as Parkinson's and Alzheimer's diseases
• Cardiovascular diseases: Including heart failure
• Mental health conditions: Like depression and anxiety
• Respiratory conditions: Such as asthma and COVID-19By integrating advanced AI and comprehensive speech analysis, we envision a future where routine health assessments are seamlessly conducted through voice, enabling early detection and proactive management of various health conditions.

• Help shape Symptonic. Take our 5-min survey

Join us in shaping the future of healthcare

We are actively seeking collaborators for pilot projects to validate and enhance our technology.If you are a healthcare provider, research institution, or technology company interested in pioneering speech-based diagnostics, we invite you to connect with us.

• Get in touch!